McKesson UK, parent company of LloydsPharmacy and AAH, has been acquired by private equity firm AURELIUS Group
Thursday 7th April 2022: McKesson UK today announces the completion of the sale of the business to private equity firm AURELIUS Group. McKesson UK, one of the UK’s leading healthcare providers, comprises LloydsPharmacy, AAH Pharmaceuticals (including Trident, Enterprise, and AAH Sangers), LloydsPharmacy Clinical Homecare, John Bell & Croyden, LloydsPharmacy Online Doctor, LloydsDirect (formerly Echo by LloydsPharmacy), and MASTA.
The completion of the sale marks McKesson UK’s transition to a standalone UK business owned by, and with strong financial backing from, AURELIUS. The UK business, formerly part of McKesson Corporation, will operate the whole of its businesses as normal and will continue its mission to become the UK’s leading omni-channel healthcare provider. AURELIUS will ensure a smooth transition as the UK business separates from its former US-based parent company, McKesson Corporation.
McKesson UK provides vital medicines, healthcare services, and clinical care every day, which has been essential throughout the Covid-19 pandemic. The new ownership will enable the business to expedite its business transformation strategy, including digital transformation, continuing our sustainability agenda, and building on our reputation as a trusted healthcare provider and partner for the NHS.
Toby Anderson, CEO of McKesson UK, comments:
“The acquisition of McKesson UK by AURELIUS Group marks the start of a new and exciting chapter for our business. It will enable us to be more agile, focused on UK partnerships and patients, and gives us the opportunity to build on the progress we have already made in delivering our business strategy. We are on a mission to become the UK’s leading omni-channel healthcare provider and our new relationship with AURELIUS means we will reach that aspiration sooner.
“AURELIUS has a proven track record in helping businesses like ours reach their full potential, and they share our deep commitment to serving customers. Under their ownership, and with our strong leadership team, we’ll accelerate our business strategy to deliver a sustainable, profitable business, as well as enhancing the value and service we provide to our NHS partners, customers, and patients.”